
According to reports from ET Now, Radico Khaitan delivered robust fourth-quarter results with net sales of ₹1,503.71 crore for the quarter ended March 2026, representing a 15.3% increase from ₹1,304.08 crore in the corresponding quarter last year. The company's EBITDA stood at ₹290.30 crore, marking a significant 62.2% rise from ₹178.99 crore recorded in March 2025. Following these strong financial results, the company's shares settled over 4% lower, down ₹145 at ₹3,438.55. As per Univest, the stock is currently trading near its 52-week high of ₹3,679, with shares at ₹3,572 representing only a 2.9% discount to this peak, indicating genuine underlying demand momentum.
As reported by ET Now, global brokerage firm Nuvama Wealth Management has reiterated a 'Buy' call on Radico Khaitan after the company reported its Q4 results. The brokerage has maintained a bullish outlook on the stock and expects further upside from current levels, with the target price set at ₹4,285 based on FY29E earnings estimates. The stock is expected to turn nearly debt-free by FY27E, which could improve return ratios and support RoCE expansion over the medium term. At the current trading levels, the stock trades at a PE ratio of 78.68 times, reflecting the market's premium valuation for sustained volume growth in the prestige segment.
According to ET Now, Radico Khaitan has demonstrated strong long-term performance with nearly 29.8% returns in the last three months, 40.5% over one year, and 110% over two years. The longer-term compounding story is even stronger, with the stock gaining nearly 196% in three years, 449% in five years, and an extraordinary 3,962% over the past decade. The company's premiumisation strategy, shifting from economy to prestige and above categories, serves as the primary margin and growth driver. India's rising disposable income, expanding urban middle class and growing cultural acceptance of premium spirits are secular tailwinds for Radico's core portfolio, with the company operating premium brands including 8 PM Premium, Magic Moments Vodka, Morpheus Brandy and Rampur Indian Single Malt Whisky.
As reported by ET Now, Nuvama said the stock remains well-positioned for strong growth and potential re-rating. The brokerage cited premiumisation-led growth, margin expansion, and strong long-term return potential as key factors supporting their positive outlook. The company's focus on premium IMFL categories and the supportive regulatory environment across key states are expected to drive continued growth and margin improvement in the coming years. With the stock trading near its 52-week high, analysts suggest that a quarterly PAT growth confirmation above 20% would serve as a key trigger for further upside, reflecting the company's strong operational performance and market positioning in India's premium spirits segment.